IDYA · IDEAYA Biosciences, Inc.
$36.30
-0.38 (-1.04%)
At close · Aug 14
Market Cap
$3.50B
Shares
96.49M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-06-23 | 2026-06-16 | |
| 8-K | 2026-06-10 | 2026-06-08 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-06-01 | — | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-29 | 2026-06-16 | |
| 8-K | 2026-04-13 | — | |
| 8-K | 2026-04-09 | 2026-04-08 | |
| 8-K | 2026-02-17 | — | |
| 10-K | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2025-12-12 | 2025-12-09 | |
| 8-K | 2025-12-05 | 2025-12-04 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-10-20 | 2025-10-17 | |
| 8-K | 2025-09-08 | 2025-09-07 | |
| 8-K | 2025-09-02 | 2025-08-29 | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-06-27 | 2025-06-26 | |
| 8-K | 2025-06-24 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-30 | 2025-06-24 | |
| 8-K | 2025-04-02 | 2025-03-28 | |
| 10-K | 2025-02-18 | 2024-12-31 | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2025-02-10 | — | |
| 8-K | 2024-12-30 | 2024-12-27 | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-10-25 | — | |
| 8-K | 2024-10-04 | — | |
| 8-K | 2024-09-23 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 10-Q/A | 2024-08-06 | 2024-03-31 | |
| 8-K | 2024-07-31 | 2024-07-30 | |
| 8-K | 2024-07-11 | 2024-07-09 | |
| 8-K | 2024-07-09 | — | |
| 8-K | 2024-07-08 | — | |
| 8-K | 2024-06-27 | 2024-06-21 |
Showing 1–50 of 136 filings
Key facts
CIK
1676725
CUSIP
45166A102
13F (30d)
271 filings
265 filers
Visit website
Investor relations